Factors Associated With Insomnia in Patients Undergoing Hemodialysis.
depression
fatigue
hemodialysis
insomnia
sleep disorders
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
14
02
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Insomnia is the most common sleep disorder among patients on hemodialysis and has a strong relation with fatigue, depression, low immune system, increased risk of cardiovascular problems, and low quality of life. The aim of this study was to explore the factors associated with insomnia in patients undergoing hemodialysis. Methods: In this cross-sectional study, 100 patients on hemodialysis (75 males and 25 females) from a hemodialysis center in Greece were included. Insomnia was assessed via the "Athens Insomnia Scale (AIS)" and a questionnaire about demographic and clinical characteristics. The Kruskal-Wallis, Mann-Whitney tests, and Spearman's rho criterion were used to evaluate the association between insomnia score and patients' characteristics. Multiple linear regression was performed to assess the effect of characteristics on patients' insomnia. Statistically significantly high levels of insomnia were found in patients over the age of 60 years (p = 0.002), in divorced/widowed patients (p = 0.007), in patients who had comorbid diseases (p = 0.001), in patients who felt tired after hemodialysis (p = 0.001), in those who had continuous fatigue (p = 0.001) and change in body image (p = 0.003), in those who often had itching (p = 0.007) and stiffness in joints (p = 0.001) and in patients who had limitations in the clothes they could wear (p = 0.001). The findings of this study showed that insomnia had a strong association with increased age of patients, comorbidities, fatigue, change in body appearance, pruritus, and limitation in clothes they could wear. Therefore, there is a necessity for early assessment of sleep quality and effective treatment of sleep disorders in hemodialysis patients in order to reduce morbidity and mortality and improve the quality of their life.
Identifiants
pubmed: 35308769
doi: 10.7759/cureus.22197
pmc: PMC8925937
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e22197Informations de copyright
Copyright © 2022, Benetou et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Saudi Med J. 2018 Aug;39(8):792-798
pubmed: 30106417
Int Urol Nephrol. 2018 Jan;50(1):143-154
pubmed: 29159509
Nat Rev Nephrol. 2021 Mar;17(3):147-148
pubmed: 33479446
Int J Nephrol. 2021 May 26;2021:5533416
pubmed: 34136284
J Psychosom Res. 2000 Jun;48(6):555-60
pubmed: 11033374
Nephrourol Mon. 2016 Jan 09;8(1):e29527
pubmed: 26981494
Kidney Blood Press Res. 2018;43(3):1000-1009
pubmed: 29913453
Am J Nephrol. 2013;38(6):489-95
pubmed: 24335380
Southwest J Pulm Crit Care. 2019;18(5):122-134
pubmed: 31360612
Front Psychiatry. 2021 Jul 19;12:576050
pubmed: 34349673
Blood Purif. 2020;49(4):419-425
pubmed: 31910406
BMC Nephrol. 2020 Oct 20;21(1):443
pubmed: 33081705
Clin J Am Soc Nephrol. 2017 Apr 3;12(4):687-693
pubmed: 28148557
Int Urol Nephrol. 2018 Aug;50(8):1467-1476
pubmed: 29779116
Glob J Health Sci. 2015 Oct 21;8(6):109-20
pubmed: 26755472
Cureus. 2021 Feb 21;13(2):e13477
pubmed: 33777565
Saudi J Kidney Dis Transpl. 2017 Sep-Oct;28(5):1112-1118
pubmed: 28937071
Cureus. 2020 Aug 2;12(8):e9520
pubmed: 32884876
Saudi J Kidney Dis Transpl. 2020 Mar-Apr;31(2):454-459
pubmed: 32394919
World J Nephrol. 2016 May 6;5(3):224-32
pubmed: 27152260
Clin Kidney J. 2021 Jan 19;14(9):2029-2036
pubmed: 34476089
Medicina (Kaunas). 2019 Oct 17;55(10):
pubmed: 31627446